Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report
admin 26th October 2017 Uncategorised 0GlaxoSmithKline and Reckitt Benckiser have already declared their interest in Pfizer’s consumer health unit. But they likely won’t be alone when bidding kicks off.
More: Sanofi, J&J could join GlaxoSmithKline, Reckitt in B bidding war for Pfizer OTC: report
Source: fierce